obesity drug news today glp-1 september 2025 The first of three of our Appetite for Answers series! Understanding GLP-1s Beyond the Headlines medications are currently a major topic of discussion, and unfortunately, misinformation is spreading—not only among the GLP-1 and Dual GIP/GLP-1 Agonists

Asthma: Tell your doctor if you have asthma before using an inhaled form

Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction

Ener K, Aldemir M, Isik E, et al

dose-dependent GI adverse events (nausea, vomiting) similar to other amylin analogues Exposure: Dose-proportional increases in Cmax and AUC Gastric Effects: Dose-dependent slowing of gastric emptying confirmed via paracetamol absorption test Appetite Suppression: Reduced ad libitum food intake at doses 1.2 mg Clinical Significance: Established feasibility of once-weekly dosing and identified dose range for Phase 2 studies

Could I try high-dose oral therapy first